Clinical outcomes in very low birth weight infants with major congenital heart defects

Anna W Anderson1, P Brian Smith2, Kristin M Corey3

  • 1Texas A&M University, College Station, TX, USA.

Early Human Development
|December 3, 2014
PubMed

Insights

Major congenital heart disease (CHD) in premature infants is linked to high mortality and morbidity. Despite advancements, survival rates and the incidence of major complications in these vulnerable infants have not improved over time.

Area of Science:

  • Neonatal care
  • Pediatric cardiology
  • Public health

Background:

  • Major congenital heart disease (CHD) combined with prematurity presents significant challenges.
  • Previous research has not fully detailed the morbidity and mortality risks for this specific patient group.

Purpose of the Study:

  • To investigate the outcomes of very low birth weight (VLBW) infants diagnosed with major CHD.
  • To describe trends in mortality and morbidity over time within this population.

Main Methods:

  • A retrospective cohort study was conducted using data from 1997 to 2012.
  • Infants weighing less than 1500 grams with major CHD from neonatal intensive care units were included.
  • Outcomes were analyzed based on birth weight, type of CHD, and time period.

Main Results:

  • Out of 105,539 VLBW infants, 299 (0.3%) had major CHD.
  • The most common CHDs were coarctation of the aorta, atrioventricular septal defect, and tetralogy of Fallot.
  • Overall mortality was 55%, with significant variation by lesion type. Mortality did not change significantly over the study period (1997-2012).
  • 73% of infants experienced at least one comorbidity or died.

Conclusions:

  • Major CHD in VLBW infants is associated with substantial morbidity and mortality.
  • While specific lesion types influence survival, overall survival rates and the incidence of major morbidities have remained stagnant.
  • There is a critical need for improved management strategies for premature infants with complex heart conditions.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
490
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
724
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
442
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.6K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
963
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
513